In Other Journals

Ann Gregory
Med J Aust 2008; 188 (3): . || doi: 10.5694/j.1326-5377.2008.tb01570.x
Published online: 4 February 2008

Platelet-activating factor (PAF) and PAF acetylhydrolase have been identified as important mediators of anaphylaxis in humans, according to Canadian researcher Vadas and colleagues. PAF is a proinflammatory phospholipid secreted by mast cells, monocytes and fixed tissue macrophages; PAF acetylhydrolase is the enzyme that inactivates PAF. In a two-part study, they found that: (1) mean serum PAF levels were not only higher in 41 patients with anaphylaxis than in 23 healthy volunteers but were also correlated with the severity of anaphylaxis; and (2) that serum PAF acetylhydrolase activity was lower in nine patients with fatal peanut anaphylaxis than patients in any of several control groups. They suggested that failure of PAF acetylhydrolase to inactivate PAF may contribute to the severity of anaphylaxis.

  • Ann Gregory



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.